{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:14:50Z","timestamp":1761812090799,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.wneu.2018.08.203","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T02:53:34Z","timestamp":1536202414000},"page":"125-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pediatric Case of Li-Fraumeni Syndrome Complicated with Supratentorial Anaplastic Ependymoma"],"prefix":"10.1016","volume":"120","author":[{"given":"Tomohiro","family":"Hosoya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kambe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Maegaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.08.203_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1947601911413466","article-title":"Li-Fraumeni syndrome","volume":"2","author":"Malkin","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.wneu.2018.08.203_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li-Fraumeni syndrome: clinical characteristics of families with p53 germline mutations","volume":"27","author":"Gonzalez","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2018.08.203_bib3","first-page":"6643","article-title":"Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype","volume":"63","author":"Olivier","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2018.08.203_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2009.073429","article-title":"TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes","volume":"47","author":"Ruijs","year":"2010","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.wneu.2018.08.203_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jmg.2005.036319","article-title":"Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes","volume":"43","author":"Evans","year":"2006","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.wneu.2018.08.203_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajhg.2010.10.007","article-title":"A\u00a0common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes","volume":"87","author":"Shlien","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.wneu.2018.08.203_bib7","first-page":"5358","article-title":"A\u00a0cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2018.08.203_bib8","first-page":"1298","article-title":"Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families","volume":"54","author":"Birch","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2018.08.203_bib9","first-page":"101","article-title":"Germline mutations in the TP53 gene","volume":"25","author":"Eeles","year":"1995","journal-title":"Cancer Surv"},{"key":"10.1016\/j.wneu.2018.08.203_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10185","article-title":"Germline TP53 mutations and Li-Fraumeni syndrome","volume":"21","author":"Varley","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.wneu.2018.08.203_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pbc.23086","article-title":"Supratentorial ependymoma in children: to observe or to treat following gross total resection?","volume":"58","author":"Venkatramani","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.wneu.2018.08.203_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000028683","article-title":"Treatment of intracranial ependymoma by surgery alone","volume":"29","author":"Hukin","year":"1998","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.wneu.2018.08.203_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s003810050487","article-title":"The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases","volume":"16","author":"Palma","year":"2000","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.wneu.2018.08.203_bib14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00381-009-0809-7","article-title":"New chemotherapy strategies and biological agents in the treatment of childhood ependymoma","volume":"25","author":"Wright","year":"2009","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.wneu.2018.08.203_bib15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/cncr.22961","article-title":"Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children\u2019s Oncology Group","volume":"110","author":"Nicholson","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2018.08.203_bib16","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood.V98.6.1979","article-title":"Solid tumors after chronic lymphocytic leukemia","volume":"98","author":"Hisada","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2018.08.203_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2169\/internalmedicine.44.490","article-title":"A\u00a0patient with TP53 germline mutation developed Bowen\u2019s disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer","volume":"44","author":"Kuribayashi","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.wneu.2018.08.203_bib18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.5858\/2009-0015-OA.1","article-title":"Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome","volume":"134","author":"Talwalkar","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.wneu.2018.08.203_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-016-2155-4","article-title":"Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study","volume":"129","author":"Jakacki","year":"2016","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.08.203_bib20","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/cam4.713","article-title":"Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021","volume":"5","author":"Wetmore","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.wneu.2018.08.203_bib21","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/1535-7163.MCT-17-1185","article-title":"Identification of FDA-approved oncology drugs with selective potency in high-risk childhood ependymoma","volume":"17","author":"Donson","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.wneu.2018.08.203_bib22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/0008-5472.CAN-14-2305","article-title":"VEGF-A expression correlates with tp53 mutations in non-small cell lung cancer: implications for antiangiogenesis therapy","volume":"75","author":"Schwaederl\u00e9","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2018.08.203_bib23","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1158\/1535-7163.MCT-16-0196","article-title":"TP53 alterations correlate with response to VEGF\/VEGFR inhibitors: implications for targeted therapeutics","volume":"15","author":"Wheler","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.wneu.2018.08.203_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.18632\/oncotarget.974","article-title":"P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy","volume":"4","author":"Said","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2018.08.203_bib25","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1212\/WNL.0b013e3181c1df34","article-title":"Bevacizumab for recurrent ependymoma","volume":"73","author":"Green","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2018.08.203_bib26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/neuonc\/nos213","article-title":"Lack of efficacy of bevacizumab\u00a0+ irinotecan in cases of pediatric recurrent ependymoma\u2014a Pediatric Brain Tumor Consortium study","volume":"14","author":"Gururangan","year":"2012","journal-title":"Neuro Oncol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018319892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018319892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:11:11Z","timestamp":1761811871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875018319892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":26,"alternative-id":["S1878875018319892"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.08.203","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Case of Li-Fraumeni Syndrome Complicated with Supratentorial Anaplastic Ependymoma","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.08.203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}